Navigation Links
PQ Bypass Graduates from the Fogarty Institute for Innovation, Establishes Independent Operations
Date:12/6/2012

MOUNTAIN VIEW, Calif., Dec. 6, 2012 /PRNewswire/ -- The Fogarty Institute for Innovation proudly announced today that PQ Bypass, a resident of the Institute and participant in its Innovator Support Program, has received its Series A financing and will be establishing independent operations in Sunnyvale, Calif., as of January 1, 2013, effectively 'graduating' from the program.   

"The goal of the Innovator Support Program is to provide companies like PQ Bypass with access to the physical and intellectual resources that will enable them to cultivate their innovations faster and ultimately reach patients," said Frederick St. Goar, M.D., F.A.C.C., Board member of the Fogarty Institute.   "We congratulate PQ Bypass for securing their Series A financing and wish them continued success as they forge ahead." 

PQ Bypass has developed a percutaneous approach to achieving a long-lasting, robust bypass in the femoral artery with results that are comparable to surgical bypass, but without the patient morbidity or hospital stay costs.

"Our experience at the Fogarty Institute was second to none; we are beyond grateful for the support we received over these last 2 years," said Richard A. Lotti, president and CEO, PQ Bypass.  "We are energized to enter this next stage of our Company's development and would encourage other companies or individuals to consider participating in this program."

For early stage (pre-A-round) medical innovators seeking to participate in the Innovator Support Program, the Institute is currently accepting applications.  Selected innovators will house their nascent companies at the Fogarty Institute in Mountain View, CA and will have access to physician and business mentoring, clinical access, laboratory/office space, and financial aid.  They will have access to clinical experience and clinical trial management services available through El Camino Hospital and the Institute's Taft Center for Clinical Research.  

Eligibility criteria include:

  • Unfunded or modestly funded innovators who need support building the technical and/or business validation needed to attract an initial round of financing (typically an "A-round")
  • Individuals or small teams
  • Innovators who, while they are working on their idea with the support of the Fogarty Institute, are able to work at the Fogarty Institute facility in Mountain View, CA
  • Innovators who will significantly benefit from the unique educational resources (e.g. mentoring and clinical access) provided by the Institute
  • Innovators whose ideas address a major unmet clinical need, or provide an opportunity to significantly improve an existing treatment method

Applications for the Innovator Support Program are due January 9, 2013, and an application and instructions can be found online at: http://www.fogartyinstitute.org/innovation.html

About The Fogarty Institute for Innovation
The Fogarty Institute for Innovation is 501(c)3 educational  non-profit organization that serves to improve patient care by supporting medical  innovation. Its educational activities involve teaching the skills and methodology necessary for medical innovators to translate their ideas into new patient therapies. The Institute and its affiliated Taft Center for Clinical Research are located on the campus of El Camino Hospital in Mountain View, Calif. To learn more about our organization, visit www.fogartyinstitute.org.

About El Camino Hospital
El Camino Hospital is an acute-care, 443-bed, not-for-profit and locally governed organization with campuses in Mountain View and Los Gatos, Calif.  In addition to state-of-the-art emergency departments, key medical specialties include heart and vascular, cancer care, urology, orthopedic and spine, neuroscience, genomic medicine, and the only Women's Hospital in Northern California.  The hospital is recognized as a national leader in the use of health information technology and wireless communications, and has been awarded the Gold Seal of Approval from The Joint Commission as a Primary Stroke Center as well as back-to-back ANCC Magnet Recognitions for Nursing Care.  To learn more, visit the El Camino Hospital website, find them on Facebook, follow them on Twitter, or view videos on YouTube. For a physician referral, visit the website or call the El Camino Health Line at 800-216-5556.


'/>"/>
SOURCE El Camino Hospital
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Spiral Flow[TM] Grafts Offer Superior Clinical Outcomes in Prosthetic Bypass Grafting
2. Medical Sales College Boasts An 81.99% Placement Rate For 2011 Graduates
3. Exclusive Industry Panel for Medical Device Developers - "The Great Innovators: A Sit-Down Chat with Dr. Thomas Fogarty & Dean Kamen"
4. UBM Canon, the Global MedTech Authority, and the Medical Design Excellence Awards Honored Dr. Thomas Fogarty with the 2012 Lifetime Achievement Award
5. Austen BioInnovation Institute in Akron Attracts Nationally Known Speakers For Conference on Value-driven Engineering, April 23-24
6. Midwest Orthopaedics at Rush Minimally Invasive Spine Institute Opens Today
7. Galenea to Receive $6 Million From The Stanley Medical Research Institute to Progress Pro-Cognitive Drug Discovery and Development Program
8. Remedy Informatics Cardiovascular Registry Selected by World-Renowned Cleveland Clinic Heart and Vascular Institute
9. University Hospitals Case Medical Centers Harrington Discovery Institute Launches Grant Program to Accelerate Drug Discovery and Development
10. Roskamp Institute Reports Beneficial Effects of Nutritional Supplementation with Anatabine in an Animal Model of Multiple Sclerosis
11. The Rogosin Institute and Hebrew Home Collaborate to Provide New Dialysis Service for Residents and Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Va. , June 24, 2016 The ... set of recommendations that would allow biopharmaceutical ... (HCEI) with entities that make formulary and coverage decisions, ... the "value" of new medicines. The recommendations ... does not appear on the drug label, a prohibition ...
(Date:6/24/2016)... , June 24, 2016 ... Market by Type (Standard Pen Needles, Safety Pen Needles), ... (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) ... MarketsandMarkets, This report studies the market for the forecast ... to reach USD 2.81 Billion by 2021 from USD ...
(Date:6/23/2016)...  MedSource announced today that it has selected ... of choice.  This latest decision demonstrates MedSource,s commitment ... clients by offering a state-of-the-art electronic data capture ... as the EDC platform of choice in exchange ... has long been a preferred EDC platform by ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... professionals, announced today its affiliation with Tennessee Counseling Association. This new ... network of the Tennessee Counseling Association, adding exclusive benefits and promotional offers. , ...
(Date:6/26/2016)... , ... June 26, 2016 , ... On June 10-11, ... of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, ... the city’s history as home to some of the world’s leading providers of cereal ...
(Date:6/25/2016)... Washington, D.C. (PRWEB) , ... June 25, 2016 ... ... will discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June ... share their work on several important health care topics including advance care planning, ...
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/24/2016)... ... 24, 2016 , ... Those who have experienced traumatic events may suffer from ... avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid this ... coping following a traumatic event. , Trauma sufferers tend to feel a range of ...
Breaking Medicine News(10 mins):